Laurus Labs (LAURUSLABS) Share Price Falls 8.51% to Rs 2,214.00: Price Action and Fundamental Analysis
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
The Laurus Labs share price fell 8.51% on 16 November 2026, with Laurus Labs last trading at Rs 2,214.00 against a previous close of Rs 2,420.00, a decline of Rs 206.00 per share as of 2:07:47 PM IST. The company carries a market capitalisation of Rs 1,30,755.56 crore and belongs to the Large Cap category within Healthcare.
This Laurus Labs share price fall places the pharmaceutical stock among the notable decliners of the session. The latest Univest figures show a price-to-earnings ratio of 97.59, return on equity of 18.31% and return on capital employed of 18.20%. Investors tracking Laurus Labs stock analysis today can use the price action, fundamentals and peer context below to see how the stock compares with others in Pharmaceuticals & Drugs, and what to monitor next as the session continues.
Laurus Labs (LAURUSLABS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,214 |
| Previous Close | Rs 2,420 |
| Today's Move | -Rs 206.00 (-8.51%) |
| Open | Rs 2,439.7 |
| High | Rs 2,439.7 |
| Low | Rs 2,214 |
| Market Capitalisation | Rs 1,30,755.56 crore |
| Market Cap Category | Large Cap |
The Laurus Labs share price today stands at Rs 2,214.00, down 8.51% from the previous close of Rs 2,420.00. The stock opened at Rs 2,439.70, which also remains the day’s high, and has since slipped to a low of Rs 2,214.00, the same level at which it last traded.
That sequence matters for the Laurus Labs share price update. The stock began the session above its previous close, yet every rupee of the decline of Rs 206.00 has come after the opening print, leaving the latest price sitting exactly on the day’s low. According to Univest data, this makes the Laurus Labs stock falling today a steady move through the session rather than a gap-down at the open.
With a market capitalisation of Rs 1,30,755.56 crore, Laurus Labs is classified as a Large Cap company. A fall of this size in a Large Cap name draws attention because the Laurus Labs market cap is far above the industry median of Rs 698.04 crore. Because the stock is still trading, the Laurus Labs share price live reading can change by the hour, and the figures here are stated as of 2:07:47 PM IST. The next section sets the price move against the company’s reported ratios.
Why Laurus Labs (LAURUSLABS) May Be Moving Today
Laurus Labs (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,30,755.56 crore |
| P/E Ratio | 97.59x |
| P/B Ratio | 21.57x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 24.8 |
| Book Value Per Share | Rs 112.17 |
| Dividend Yield | 0.08% |
Laurus Labs (LAURUSLABS) fundamental metrics show P/E 97.59x, P/B 21.57x, ROE 18.31%, ROCE 18.2%. Read together, these ratios describe the company’s position rather than a recommendation.
Laurus Labs has a market capitalisation of Rs 1,30,755.56 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 97.59x, P/B at 21.57x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.8, book value per share of Rs 112.17, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 97.59x |
| Benchmark Median P/E | 30.93x |
| Benchmark Average P/E | 52.22x |
| Benchmark P/E Range | 2.6x to 1,177x |
| Company P/B Ratio | 21.57x |
| Benchmark Median P/B | 2.9x |
| Benchmark Average P/B | 3.43x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 10.98% |
| Benchmark Average ROE | 4.7% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 12.63% |
| Benchmark Average ROCE | 3.14% |
| Company Market Capitalisation | Rs 1,30,755.56 crore |
| Benchmark Median Market Cap | Rs 698.04 crore |
| Benchmark Average Market Cap | Rs 14,540.61 crore |
Laurus Labs (LAURUSLABS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Laurus Labs (LAURUSLABS) has a P/E ratio of 97.59x, which is above the benchmark median of 30.93x, a difference of +215.52%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Laurus Labs (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 10.98%, a difference of +66.76%. Laurus Labs (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 12.63%, a difference of +44.1%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,51,290.91 | 41.15 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 3,05,014.11 | 90.7 | 16.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,77,333.2 | 83.49 | 9.65 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,802.71 | 28.42 | 4.27 | 19.69 | 21.39 |
| Dr. Reddy's Laboratories | DRREDDY | 1,15,016.89 | 41.08 | 2.96 | 11.69 | 13.75 |
Laurus Labs (LAURUSLABS) has a P/E ratio of 97.59x compared with the displayed peer median of 41.15x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 18.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Laurus Labs (LAURUSLABS) has a market capitalisation of Rs 1,30,755.56 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- The Laurus Labs share price fell 8.51%, from Rs 2,420.00 to Rs 2,214.00, during the session.
- The stock is trading at the day’s low of Rs 2,214.00 after opening at Rs 2,439.70.
- The price-to-earnings ratio of 97.59 is above the industry median of 30.93.
- Return on equity of 18.31% and return on capital employed of 18.20% are above industry medians.
- The market capitalisation of Rs 1,30,755.56 crore places Laurus Labs among the larger Healthcare names.
About Laurus Labs
Laurus Labs is a listed company in the Healthcare sector, operating within the Pharmaceuticals & Drugs industry. The industry covers the development and manufacture of medicines and related products, and companies in it earn revenue by supplying those products to customers. Laurus Labs is categorised as Large Cap, and its shares are traded on the NSE and BSE.
Within the industry benchmark of 205 companies, Laurus Labs ranks among the larger names by market capitalisation, with a reported return on equity of 18.31% and a return on capital employed of 18.20%. These company financials, set beside the peer and sector figures, give a fuller picture than the price move alone.
Track Laurus Labs Share Price on Univest
Use Laurus Labs (LAURUSLABS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers who follow the Laurus Labs share price can track the live price, fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights on Univest. The platform keeps the latest figures for Laurus Labs and its Pharmaceuticals & Drugs peers in one place, so the price action, valuation and sector comparison covered above can be revisited as the session moves on. Univest also lists other Healthcare stocks for side-by-side reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is the Laurus Labs share price today?
Ans. The Laurus Labs share price today is Rs 2,214.00 as of 2:07:47 PM IST on 16 November 2026, down 8.51% from the previous close of Rs 2,420.00. The stock opened at Rs 2,439.70 and is trading at the day's low.
How much has the Laurus Labs share price fallen today?
Ans. The Laurus Labs share price has fallen by Rs 206.00 per share, or 8.51%, from the previous close of Rs 2,420.00 to Rs 2,214.00. The decline came after the stock opened at Rs 2,439.70, which is also the day's high.
What is the market capitalisation of Laurus Labs?
Ans. Laurus Labs has a market capitalisation of Rs 1,30,755.56 crore and is classified as a Large Cap company. The industry benchmark median is Rs 698.04 crore, so the company sits well above the typical Pharmaceuticals & Drugs name.
What is the P/E ratio of Laurus Labs?
Ans. Laurus Labs has a price-to-earnings ratio of 97.59 against an industry median of 30.93 and an average of 52.22. Earnings per share is Rs 24.80, which is the earnings attributable to each share.
What are the ROE and ROCE of Laurus Labs?
Ans. Laurus Labs reports a return on equity of 18.31% and a return on capital employed of 18.20%. The industry medians are 10.98% for ROE and 12.63% for ROCE, so both company figures sit above the benchmark.
What is the book value and dividend yield of Laurus Labs?
Ans. Book value per share is Rs 112.17, which reflects the accounting net worth behind each share, and the price-to-book multiple is 21.57. The dividend yield is 0.08%, a historical measure relative to the current price.
How does Laurus Labs compare with its peers?
Ans. Laurus Labs has a P/E of 97.59, above Divi's Laboratories at 90.70 and Torrent Pharmaceuticals at 83.49. Its ROE of 18.31% is above Sun Pharmaceutical at 14.85% but below Torrent Pharmaceuticals at 26.76%.
Which sector and industry does Laurus Labs belong to?
Ans. Laurus Labs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The industry benchmark used here covers 205 companies, and Laurus Labs is a Large Cap name within that group by market capitalisation.
Where can investors track the Laurus Labs share price?
Ans. Investors can track the live Laurus Labs share price, valuation ratios, 52-week levels and peer figures on Univest. The page also shows the sector context for Pharmaceuticals & Drugs, so price moves can be read alongside fundamentals.